Nicholas A. Saccomano - President and CEO, Director at OnKure Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Stock Symbol
OKUR on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Nicholas A. Saccomano since 12/22/2023

Holdings reported by Nicholas A. Saccomano for OnKure Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Employee Stock Option (right to buy) 542K Oct 4, 2024 Direct Class A Common Stock
Class A Common Stock 4.56K Oct 4, 2024 Direct

Transactions reported by Nicholas A. Saccomano for OnKure Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.